Targacept (TRGT)
Targacept Market Cap: 138.61M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TRGT Market Cap Rankings
| Overall | 28th percentile | 3356 of 4665 |
| Sector | 37th percentile | 328 of 527 in Healthcare |
| Industry | 43rd percentile | 92 of 164 in Biotechnology |
TRGT Market Cap Range, Past 5 Years
| Minimum | 61.18M | Jun 2009 |
| Maximum | 771.64M | Mar 2011 |
| Average | 349.39M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these TRGT related companies
TRGT News
Listen to $TRGT Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3f5M
about 29 days ago by earningscast
about 29 days ago by earningscast
Targacept (TRGT) to Reduce Workforce by 65; Clinical Development SVP Dunbar to Retire
Apr 25, 9:11AM Street Insider
Apr 25, 9:11AM Street Insider
Targacept Announces Reduction in Force and Plan to Focus Resources on Later-Stage Pipeline
Apr 25, 9:10AM Business Wire
Apr 25, 9:10AM Business Wire
Targacept to Report First Quarter 2012 Financial Results on May 3, 2012
Apr 24, 8:55AM Business Wire
Apr 24, 8:55AM Business Wire
$TRGT getting some interest after Barron’s noted that it could be long-ball stock triple. Stock is down 80% and has a poor record so far.
about 45 days ago by abubnic
about 45 days ago by abubnic
$TRGT very bullish Barron's article cites analyst looking for a triple..loaded with cash & multi-drug pipeline
about 45 days ago by drstock2008
about 45 days ago by drstock2008
$TRGT good potential here for modest gains - they have cash and active partner, and a nice pipe to boot http://stks.co/3Mpr
about 47 days ago by rickz
about 47 days ago by rickz
Targacept (TRGT) Reports ID Error in Revised Top-Line Results from TC-6987 Phase 2
Apr 10, 8:57AM Street Insider
Apr 10, 8:57AM Street Insider
Targacept (TRGT) revises top-line results from exploratory Phase 2 study of TC-6987 in asthma, found error in app
Apr 10, 8:56AM Street Insider
Apr 10, 8:56AM Street Insider
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 Study of TC-6987 in Asthma
Apr 10, 8:55AM Business Wire
Apr 10, 8:55AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TRGT | 4.14 | -0.01 | -0.24% | 138.61M |
| TRGP | 42.53 | -1.81 | -4.08% | 1.878B |
| TRF | 12.80 | -0.39 | -2.96% | |
| TREX | 27.05 | -2.05 | -7.04% | 455.42M |
| TREE | 8.95 | -0.08 | -0.89% | 99.78M |
| TRC | 25.29 | -1.35 | -5.07% | 532.53M |
| TRAK | 25.75 | -1.55 | -5.68% | 1.145B |
| TCB | 10.99 | -0.80 | -6.79% | 1.910B |
| TCAP | 19.98 | -0.36 | -1.77% | 553.45M |
| TC | 3.44 | +0.01 | +0.29% | 576.51M |
